CTNNB1 and endometrial cancer: Altered Wnt/β‐catenin signaling, as a result of gene alterations such as those found in APC or in CTNNB1 (β‐catenin), has been reported to drive tumorigenesis in numerous tumors including endometrial cancer [30].